Effects of Remote Ischaemic Preconditioning in Cemented Hip Arthroplasty.
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Osteoarthritis, Hip, Cardiovascular Diseases, Bone Cement Implantation Syndrome, Kidney Diseases
In brief
Total joint arthroplasty is one of the best treatment options for end-stage osteoarthritis. Cemented hip arthroplasty is mainly indicated for elderly patients with poor bone quality and multiple comorbidities. Bone cement implantation syndrome is associated with cemented hip arthroplasty and it has been shown to increase cardiovascular and renal complication and brain damage postoperatively. The aim of this project is to elucidate whether remote-ischemic preconditioning (RIPC) has multi-organ protective effect in cemented hip arthroplasty patients.
Key facts
- Study ID
- NCT06323018
- Run by
- University of Tartu
- People needed
- 200
- Starts
- 2024-03-20
- Expected to finish
- 2027-03-01
- Last updated by the study team
- 2024-04-04
Who can join
Age: 65 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- age >65 years
- undergoing total hip cemented hip arthroplasty
You may not qualify if…
- previously diagnosed peripheral artery disease on both upper limb
- RIPC is contraindicated
Where it is running
- University of Tartu — Tartu, Tartu, Estonia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.